Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial.
Roopinder K SandhuJustin A EzekowitzZiad HijaziJohan WesterberghJulia AulinJohn H AlexanderChristopher B GrangerSigrun HalvorsenMichael S HannaRenato D LopesAgneta SiegbahnLars WallentinPublished in: Open heart (2018)
NCT00412984.
Keyphrases
- atrial fibrillation
- insulin resistance
- metabolic syndrome
- weight loss
- phase iii
- study protocol
- oral anticoagulants
- catheter ablation
- high fat diet induced
- phase ii
- type diabetes
- left atrial
- weight gain
- clinical trial
- left atrial appendage
- direct oral anticoagulants
- heart failure
- percutaneous coronary intervention
- randomized controlled trial
- adipose tissue
- skeletal muscle
- venous thromboembolism
- coronary artery disease
- acute coronary syndrome
- mitral valve
- double blind
- placebo controlled